Teva Pharmaceuticals, a global leader in generic medicines, has as its primary objective the improvement of patients’ lives worldwide through high-quality yet affordable medications. Teva’s medicines have been used by healthcare professionals and patients for over a century, with approximately 200 million people worldwide taking one of Teva’s medications every day.
To further support patients and healthcare systems, Teva continues to produce and launch new generic as well as innovative medicines.
In 2021, Teva Romania has launched and will continue to launch new medicines addressing various conditions. For instance, in January, the first generic medicine for advanced-stage breast cancer was introduced to the Romanian market. Breast cancer is the most common type of cancer and the leading cause of mortality in women.
At the beginning of March, an innovative medicine recommended for patients with cystic fibrosis complicated by bacterial pneumonia, a major cause of morbidity and mortality in these patients, will be launched. The medicine has been available in EU countries for several years, and it is now becoming available in Romania.
Through its endeavors, Teva continues to support healthcare systems and strives to improve patients’ health, who, in turn, will be informed by physicians about the therapeutic options available in Romania suitable for their condition.

